Trends in blood lipids and fat soluble vitamins in Catalonia, Spain (1992-2003)

Public Health Nutrition

Volumn 10, Issue 11 A, 2007, Pages 1379-1388

  Serra Majem, Lluís ^a,b,c   Pastor Ferrer, Ma Cruz ^d   Castell, Conxa ^c   Ribas Barba, Lourdes ^a   Román Viñas, Blanca ^a   Ribera, Laia Font ^a   Plasencia, Antoni ^c   Salleras, Lluis ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c Division of Public Health   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Tocopherol; Carotene; Catalonia; Cholesterol; Lipoproteins; Nutritional status; Prevalence; Retinol; Spain; Trends

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CHOLESTEROL; FAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; RETINOL; VITAMIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SPAIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALPHA-TOCOPHEROL; BETA CAROTENE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; NUTRITIONAL STATUS; SEX DISTRIBUTION; SPAIN; VITAMIN A;

EID: 36049051925     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980007000985     Document Type: Article

References (59)

1. Boix R, Medrano MJ, Almazán J. Actualización de la mortalidad por enfermedades cardiovasculares arterioscleróticas: enfermedad cerebrovascualr y enfermedad isquémica del corazón. Boletín Epidemiológico Semanal 2000; 8: 77-80.
2. Instituto Nacional de Estadística. Morbilidad hospitalaria por enfermedades cardiovasculares. España 1977-2002. Available at http://193.146.50.130/htdocs/cardiov/isquemica/isquemica.htm (Accessed 6 November 2006).
3. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002; 88(2): 119-24.
4. Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J. International trends in mortality from stroke, 1968 to 1994. Stroke 2000; 31(7): 1588-601.
5. Cerrato Crespán E, Boix Martínez R, Medrano Albero MJ. Riesgo cardiovascular en España. Boletin Epidemiológico Semanal 2004; 12: 53-6.
6. De Waart FG, Schouten EG, Stalenhoef AF, Kok FJ. Serum carotenoids, alpha-tocopherol and mortality risk in a prospective study among Dutch elderly. International Journal of Epidemiology 2001; 30(1): 136-43.
7. Buijsse B, Feskens EJ, Schlettwein-Gsell D, Ferry M, Kok FJ, Kromhout D, de Groot LC. Plasma carotene and alpha-tocopherol in relation to 10-y all-cause and cause-specific mortality in European elderly: the Survey in Europe on Nutrition and the Elderly, a Concerted Action (SENECA). American Journal of Clinical Nutrition 2005; 82(4): 879-86.
8. Voutilainen S, Nurmi T, Mursu J, Rissanen T. Carotenoids and cardiovascular health. American Journal of Clinical Nutrition 2006; 83: 1265-71.
9. Hak AE, Ma J, Powell CB, Campos H, Gaziano JM, Willett WC, et al. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke 2004; 35(7): 1584-8.
10. Jenab M, Riboli E, Ferrari P, Friesen M, Sabate J, Norat T, et al. Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition. British Journal of Cancer 2006; 95(3): 406-15.
11. Ziegler RG. Vegetables, fruits, and carotenoids and the risk of cancer. American Journal of Clinical Nutrition 1991; 53(Suppl. 1): 251S-9S.
12. Coyne T, Ibiebele TI, Baade PD, Dobson A, McClintock C, Dunn S, et al. Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. American Journal of Clinical Nutrition 2005; 82(3): 685-93.
13. Hallfrisch J, Muller DC, Singh VN. Vitamin A and E intakes and plasma concentrations of retinol, beta-carotene, and alpha-tocopherol in men and women of Baltimore Longitudinal Study of Aging. American Journal of Clinical Nutrition 1994; 60(2): 176-82.
14. Willett WC. Nutritional Epidemiology. Oxford: Oxford University Press, 1998.
15. Serra Majem L, Ribas Barba L, García Closas R, Ramon JM, Salvador G, Farran A, et al. Llibre Blanc: Avaluació de l'estat nutricional de la població catalana (1992-93). Barcelona: Departament de Sanitat i Seguretat Social, Generalitat de Catalunya, 1996.
16. Garcia Closas R, Serra Majem L, Chacón P, Olmos M, Ribas L, Salleras L, et al. Distribución de la concentración de lípidos séricos en una muestra representativa de la población adulta de Cataluña. Medicina Clinica (Barcelona) 1999; 113: 6-12.
17. Garcia Closas R, Serra Majem L, Pastor C, Olmos M, Roman B, Ribas L, et al. Distribución de la concentración sérica de β-caroteno, retinol y α-tocoferol en una muestra representativa de la población adulta de Cataluña. Medicina Clinica (Barcelona) 2002; 118(7): 256-61.
18. Puska P, ed. Comprehensive cardiovascular community control programmes in Europe. WHO Euro Reports and Study 106. Copenhague: WHO, 1988.
19. Generalitat de Catalunya, Departament de Sanitat i Seguretat Social. Document marc per a la elaboració del Pla de Salut de Catalunya. Barcelona: Departament de Sanitat i Seguretat Social, 1991.
20. Serra Majem L, Ribas Barba L, Salvador Castell G, Castell Abat C, Román Viñas B, Serra J, et al. Avaluació de l'estat nutricional de la població catalana 2002-2003. Evolució dels hàbits alimentaris i dels consum d'aliments i nutrients a Catalunya (1992-2003). Barcelona: Departament de Salut, Generalitat de Catalunya, 2006.
21. Generalitat de Catalunya, Departament de Salut. Examen de salud a la població de Catalunya de 18 a 74 anys. Barcelona: Departament de Salut, 2004. Available at http://www.gencat.net/salut/depsan/units/sanitat/pdf/ exsalcat.pdf
22. 2. Clinical Chemistry 1983; 29: 2026-30.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972; 18: 499-502.
24. Milne DB, Botnen J. Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clinical Chemistry 1986; 32: 874-6.
25. Pastor Ferrer MC, Codoceo Alquinta R, Deulofeu Piquet R, Dolacé Botias M, Farré Guerrero V, Fernández Calle P, et al. Procedimiento recomendado para la determinación de alfa-tocoferol en suero. Química Clínica 1996; 15: 445-9.
26. Pastor Ferrer MC, Codoceo Alquinta R, Deulofeu Piquet R, Dolacé Botias M, Farré Guerrero V, Fernández Calle P, et al. Evaluación de las condiciones preanalíticas y de la fase de extracción para la determinación de retinol y alfa-tocoferol en suero por cromatografía líquida de alta resolución. Química Clínica 1996; 15: 190-6.
27. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Journal of the American Medical Association 1993; 269: 3015-23.
28. Gibson RS. Principles of nutritional assessment. Oxford: Oxford University Press, 1990.
29. Fidanza F. Nutritional status assessment. A manual for population studies. London: Chapman & Hall, 1991.
30. Plans P, Ruigómez J, Pardell H, Salleras L. Distribución de lípidos en la población adulta de Cataluña. Revista Clinica Española 1993; 193: 35-42.
31. Peterson S, Peto V, Rayner M. European cardiovascular disease statistics: 2005 edition. Available at http://www.ehnheart.org/files/statistics%2005- 092711A.pdf (Accessed 12 December 2006).
32. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland, 1972-1997. International Journal of Epidemiology 2000;29(1): 49-56.
33. Kastarinen M, Tuomilehto J, Vartiainen E, Jousilahti P, Sundvall J, Puska P, et al. Trends in lipid levels and hypercholesterolemia in hypertensive and normotensive Finnish adults from 1982 to 1997. Journal of Internal Medicine 2000; 247(1): 53-62.
34. Marques Vidal P, Ruidavets JB, Amouyel P, Ducimetiere P, Arveiler D, Montaye M, et al. Change in cardiovascular risk factors in France, 1985-1997. European Journal of Epidemiology 2004; 19(1): 25-32.
35. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. Journal of the American Medical Association 2005; 294(14): 1773-81.
36. Wietlisbach V, Paccaud F, Rickenbach M, Gutzwiller F. Trends in cardiovascular risk factors (1984-1993) in a Swiss region: results of three population surveys. Preventive Medicine 1997; 26: 523-33.
37. Arnett DK, Jacobs Jr DR, Luepker RV, Blackburn H, Armstrong C, Claas SA. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation 2005; 112(25): 3884-91.
38. Tresserras R, Castell C, Pardell H. Enfermedades cardiovasculares. Evaluación de los objetivos del Plan de Salud de Cataluña para el año 2000. Medicina Clinica (Barcelona) 2003; 121(Suppl. 1): 20-5.
39. Marrugat J, Sentí M. Why mortality from heart disease is low in France. High cholesterol may not have same effect on cardiovascular risk in southern Europe as elsewhere. British Medical Journal 2000; 320(7229): 250.
40. Ferrieres J. The French paradox: lessons for other countries. Heart 2004; 90(1): 107-11.
41. Medrano MJ, Cerrato E, Boix R, Delgado-Rodríguez M. Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales. Medicina Clinica (Barcelona) 2005; 124(16): 606-12.
42. Watson R. Circulatory diseases are Europe's biggest killer. British Medical Journal 2006; 333(7561): 218.
43. Research Committee on Serum Lipid Level Survey 1990 in Japan. Current state of and recent trends in serum lipid levels in the general Japanese population. Journal of Arteriosclerosis and thrombosis 1996; 2(2): 122-32.
44. MacLean DR, Petrasovits A, Connelly PW, Joffres M, O'Connor B, Little JA. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. The Canadian Journal of Cardiology 1999; 15(4): 434-44.
45. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Stefanadis C. Status and management of blood lipids in Greek adults and their relation to socio-demographic, lifestyle and dietary factors: the ATTICA Study. Blood lipids distribution in Greece. Atherosclerosis 2004; 173(2): 353-61.
46. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, et al. Serum lipid survey and its recent trend in the general Japanese population in 2000. Journal of Atherosclerosis and Thrombosis 2005; 12(2): 98-106.
47. Direcció General de Salut Pública. Avaluació dels objectius per a l'any 2000 del Pla de Salut de Catalunya. Departament de Sanitat i Seguretat Social, Generalitat de Catalunya. Barcelona, 2003.
48. Juonala M, Viikari JS, Hutri-Kahonen N, Pietikainen M, Jokinen E, Taittonen L, et al. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference. Data from trends on prevalence of overweight and obesity and blood lipid levels. Journal of Internal Medicine 2004; 255(4): 457-68.
49. Ribas Barba L, Serra Majem L, Salvador G, Castell C, Cabezas C, Salleras L, Plasencia A. Trends in dietary habits and food consumption in Catalonia, Spain (1992-2003). Public Health Nutrition 2007; 10(11A): 1340-53.
50. Aranceta J, Perez Rodrigo C, Serra Majem L, Ribas Barba L, Quiles Izquierdo J, Vioque J, et al. Prevalence of obesity in Spain: results of the SEEDO 2000 study. Medicina Clinica (Barcelona) 2003; 120(16): 608-12.
51. Serra-Majem L, Aranceta Bartrina J, Perez-Rodrigo C, Ribas-Barba L, Delgado-Rubio A. Prevalence and determinants of obesity in Spanish children and young people. British Journal of Nutrition 2006; 96(Suppl. 1): S67-72.
52. Tolonen H, Keil U, Ferrario M, Evans A. Prevalence, awareness and treatment of hypercolesterolaemia in 32 populations: results from the MONICA Project. International Journal of Epidemiology 2005; 34(1): 181-92.
53. Serra Majem L, Ribas Barba L, Salvador G, Jover L, Raido B, Ngo J, Plasencia A. Trends in energy and nutrient intake and risk of inadequate intakes in Catalonia, Spain (1992-2003). Public Health Nutrition 2007; 10(11A): 1354-67.
54. Ford ES, Sowell A. Serum alpha-tocoferol status in the United States population: findings from the Third National Health and Nutrition Examination Survey. American Journal of Epidemiology 1999; 150(3): 290-300.
55. Elmadfa I, Weichselbaum E, Konig J, de Winter A-M R, Trolle E, Haapala I, et al. European nutrition and health report 2004. Forum of Nutrition 2005; 58: 1-220.
56. Olmedilla B, Granado F, Southon S, Wright AJ, Blanco I, Gil-Martinez E, et al. Serum concentrations of carotenoids and vitamins A, E, and C in control subjects from five European countries. British Journal of Nutrition 2001; 85: 227-38.
57. Galan P, Viteri FE, Bertrais S, Czernichow S, Faure H, Arnaud J, et al. Serum concentrations of beta-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. European Journal of Clinical Nutrition 2005; 59(10): 1181-90.
58. Ortega RM, Mena MC, Faci M, Santana JF, Serra-Majem L. Vitamin status in different groups of the Spanish population: a meta-analysis of national studies performed between 1990 and 1999. Public Health Nutrition 2001; 4(6A): 1325-9.
59. Al-Delaimy WK, van Kappel AL, Ferrari P, Slimani N, Steghens JP, Bingham S, et al. Plasma levels of six carotenoids in nine European countries: report from the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutrition 2004; 7(6): 713-22.